In crisis? Call or text 988 (Suicide & Crisis Lifeline) · Overdose emergency? Call 911
Research summary

Kratom and 7-OH Dependence: An Emerging Treatment Concern

FDA safety concerns and emerging clinical reports on dependence and withdrawal associated with concentrated 7-OH.

Published and clinically reviewed: November 21, 2026 · Source publication: 2025–2026

The FDA has raised concerns about concentrated 7-OH products because of their opioid-like effects and potential for dependence. Published clinical reports have also documented withdrawal associated with their use.

Patients experiencing difficulty reducing or stopping these products should seek an individualized medical assessment. Research into treatment approaches remains limited.

Original sources

Explore treatment options

Learn about kratom and 7-OH treatment · See all research updates

Research summaries are provided for education and do not replace individualized medical advice.

Request an appointment
Book Message